JIRacademy

Introduction

Classification criteria

Clinical manifestations not yet considered as classification criteria

Management

Question: What is the value of IgA, anticardiolipin and Beta2GP1

Question: APLA syndrome but with a negative result for APLA?

Question: Why do you think the risk ratio for IgG is higher than that for IgM?

Question: What is risk of thrombosis in patients with infection-induced APLA?

Question: In patients with thrombocytopenia as a non-thrombotic manifestation of APLA, in which platelet count do you think the use of aspirin would be safe?

Question: Is it mandatory to put SLE patients associated with APS on profilaxis treatment even if there is no tromboembolic event?

Question: Delay of 12 weeks between 2 APLA tests

Questions answered by text: Use of Rivaroxaban?

Comments from Kathleen O'Neil

Introduction

Introduction clinical case "Kimmy"

Indication for APS testing

What lab studies for suspected APS?

Lupus Anti-coagulant (LAC)

Anti-Cardiolipin Antibodies (ELISA)

Anti-B2 glycoprotein I Antibody Assay

Which test is meaningful and how to interpret

What did we do for "Kimmy"

Question: What do you think about primary APS that over time evolve into Lupus?

References for APS testing

Question: which test prioritize in a ressource challenged setting?

Cutaneous manifestation of APS: comments from Kathleen O'Neil and Tadej Avcin

Case with APS and pyoderma gangrenosum

Hematological manifestations of APS

Hematological manifestations of APS: comments from Kathleen O'Neil and Tadej Avcin

How to go forward with this case?

Quiz on APLA